Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers
TUCSON, Ariz., April 13, 2015 – The Critical Path Institute (C-Path) announced today that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have issued […]